Search

everythinglearnresearchcommunity

for

Search:↓

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Many people with hair loss had low iron and ferritin levels.

Monocytes might be linked to hair loss after COVID-19.

Painful hair loss in an elderly woman was caused by giant cell arteritis, not just aging.

People with non-scarring hair loss often have lower vitamin D levels than those without hair loss.

Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.

Trichoscopy helps diagnose and manage hair and scalp disorders in children.

COVID-19 may cause temporary hair loss due to the body's immune response.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

Certain diets may help with hair growth in people with different types of hair loss.

The study suggests pandemic stress might worsen or trigger hair loss problems.

Trichoscopy is a quick and reliable way to diagnose hair loss in women.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Ptch2 plays a key role in controlling stem cell function and the ability to regenerate after birth.

Trichoscopy is useful for diagnosing hair and scalp disorders in people with darker skin.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

The most effective way to diagnose non-scarring hair loss is by transverse sectioning, and some cases, particularly in males with inflammation around hair follicles, might be curable.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

Low iron levels in the blood could be a sign of Telogen Effluvium, a type of hair loss, but it's not always accurate in distinguishing it from other hair loss types.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Hair loss after bariatric surgery is common due to nutrient deficiencies and rapid weight loss.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

COVID-19 may cause a common type of hair loss called telogen effluvium.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Medicinal plants in Kurdistan have potential health benefits and need more research for drug development.